US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

71.78

+1.151.63%

Volume:16

Turnover:1K

Market Cap:717.92K

PE:- -

High:71.78

Open:70.64

Low:71.78

Close:70.64

52wk High:85.03

52wk Low:56.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.05

T/O Rate:0.16%

Dividend:2.07

Dividend Rate:2.89%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies

MT Newswires Live

Barclays Remains a Sell on GlaxoSmithKline (GSK)

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.

Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights

GlaxoSmithKline (GSK) Gets a Sell from Barclays

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

Gsk's HIV Franchise Seems Underappreciated

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

GSK Unit Launches Tender Offer for Nuvalent Acquisition

MT Newswires Live

GSK Discloses Executive Notional ADS Acquisition by U.S. President

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/GSKH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":71.7846,"timestamp":1789675200000,"preClose":70.6364,"halted":0,"volume":16,"delay":0,"changeRate":0.01625507528696257,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Pre-Mkt","change":1.1482,"latestTime":"09-18 06:54:33 EDT","open":70.6364,"high":71.7846,"low":71.7846,"amount":1130,"amplitude":0,"askPrice":114.13,"askSize":100,"bidPrice":28.86,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":71.7846,"nav":70.29546,"aum":703024.89546,"dividendRate":0.0289,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"volumeRatio":0.04670166839959045,"impliedVol":0.2137,"impliedVolPercentile":0.7265},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.04670166839959045,"shares":10001,"dividePrice":2.0746,"high":71.7846,"amplitude":0,"preClose":70.6364,"low":71.7846,"week52Low":56.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":71.7846,"eps":0,"divideRate":0.0289,"volume":16,"delay":0,"ttmEps":0,"open":70.6364,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":67.0681,"twentyDayClose":73.0903,"sixtyDayClose":73.662},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649856998","title":"Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2649856998","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649856998?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:00","pubTimestamp":1783508400,"startTime":"0","endTime":"0","summary":"Apple to Spend $30 Billion on U.S.-Made Chips From BroadcomThe deal, for billions of chips, is the latest part of Apple's domestic investment pledge.----Trump-Backed Company Behind Family Crypto Wealt","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1400636657.SGD","IE00B5949003.HKD","LU0501845795.SGD","LU1301847155.USD","LU2133065610.SGD","LU1699723380.USD","IE00B19Z9505.USD","LU0354030511.USD","LU1732799900.SGD","LU2322448957.HKD","IE000SO60NU8.SGD","LU2506952170.USD","FTEC","LU2065170008.USD","IE000Q6AESB8.SGD","LU0868494617.USD","LU0553294199.USD","IE00BJJMRY28.SGD","LU2271345857.HKD","LU1791710400.SGD","LU0210528500.USD","IE00BYXW3230.USD","GSKH","IE00BMPRXR70.SGD","LU1585245621.USD","IE00B3S45H60.SGD","LU2272731600.USD","LU1829250122.USD","LU0965509010.AUD","LU0130517989.USD","BK4534","IE00B19Z9Z06.USD","LU0719512351.SGD","IE0034235295.USD","TRFK","IE000F7OJYX1.SGD","BK4597","SG9999001424.SGD","SJM","BK4574","BK4573","LU0198837287.USD","LU0133085943.USD","LU0787776722.HKD","LU0708995401.HKD","HK0000914660.USD","LU0140636845.USD","LU0795875169.SGD","LU1823568750.SGD","XLP","IE00BZ08YR35.GBP","LU0353189763.USD","LU0950375773.USD","LU1582987597.SGD","LU0494093205.USD","LU0545039389.USD","LU1548497426.USD","IE0005OL40V9.USD","LU0683600562.USD","LU0154236417.USD","LU0211331839.USD","LU1868836591.USD","LU0127658192.USD","LU0210533765.USD","LU2065171311.SGD","LU2756315664.SGD","LU2602419157.SGD","LU1623119135.USD","AVGX","LU0314104364.USD","LU0466842654.USD","VT","LU2242650005.HKD","IE00B3PB1722.GBP","LU1242518931.SGD","LU0320765646.SGD","HK0000320264.USD","SG9999015358.SGD","LU2403377893.USD","IE0008368742.USD","LU2452424414.USD","IE000ITXATA3.USD","AAPL","SGXZ31699556.SGD","LU1119994496.HKD","BK4592","IE00BKDWB100.SGD","LU1720051017.SGD","SG9999014880.SGD","ACI","LU0079474960.USD","LU1645745479.HKD","BK4576","LU0345770308.USD","LU1244550221.USD","LU0130518102.USD","SG9999014914.USD","LU2298321311.HKD","LU1923623000.USD","LU2125154778.USD","LU1202635105.USD","AAPD","LU0072913022.USD","IETC","LU0528227936.USD","BK4550","LU0957808578.USD","AAPX","LU1804176565.USD","LU2237438978.USD","IE00BLSP4239.USD","LU1551013425.SGD","IE0034235303.USD","LU0316494557.USD","LU0557290698.USD","LU0345770993.USD","AZN","IE00BVYPNW00.USD","BK4566","LU2999663052.SGD","LU0109391861.USD","LU1718418525.SGD","LU1807302812.USD","IE00BZ08YS42.EUR","LU2360107325.USD","LU2720916845.USD","CGDG","LU1127390331.HKD","LU2039709279.SGD","LU1674673691.USD","LU1852331112.SGD","SG9999017495.SGD","LU1629891620.HKD","LU2092627202.USD","LU0097036916.USD","LU0158827781.USD","BK4516","IE00BMPRXN33.USD","LU2065171402.SGD","LU0082616367.USD","LU3102509885.SGD","LU1206713676.USD","AZNH","LU1670710661.SGD","AVL","LU2089985449.USD","BK4605","HK0000819398.USD","LU2089283258.USD","LU0225283273.USD","LU2860962120.EUR","CHAT","LU2237443465.HKD","LU0823434583.USD","LU2095319765.USD","LU0310799852.SGD","LU1235294995.USD","IE0008369823.USD","SG9999015945.SGD","ARTY","IE00BYV24P56.USD","IE00BKVL7J92.USD","IE00BVYPNV92.GBP","LU1244550577.SGD","IE00BFSS7M15.SGD","IE0000B7K699.USD","SG9999003800.SGD","LU2097344357.USD","LU1582987324.SGD","LU1814569148.SGD","LU1267930730.SGD","SMHX","LU2286300806.USD","LU2264538146.SGD","APLY","LU1989764664.SGD","TEK","LU0061474960.USD","LU2463028550.USD","CIBR","LU1003077747.HKD","LU2355687059.USD","BK4170","FSTA","LU1778281490.HKD","LU0081259029.USD","SG9999018857.SGD","TYLG","LU2244417387.USD","WMT","IE0034235188.USD","LU1791710582.SGD","AIFD","LU1861219969.SGD","TDIV","LU2764263039.SGD","DJTWW","LU2433249047.HKD","IE0004445239.USD","LU1323610961.USD","LU2361044865.SGD","IE0004086264.USD","LU1934455277.USD","LU0058720904.USD","IE0009G5SDU7.USD","LU1116320901.HKD","LU0061475181.USD","CGGO","LU0912757837.SGD","LU2487616109.SGD","LU2063271972.USD","LU2041044095.USD","LU0353189680.USD","LU0238689110.USD","LU0053666078.USD","LU0109392836.USD","LU0738911758.USD","LU0949170426.SGD","LU1670711123.USD","LU0203202063.USD","IE000KEQY171.SGD","LU2458330169.SGD","LU2361045086.USD","HK0000914686.HKD","LU2456880835.USD","LU0128525929.USD","LU1917777945.USD","KURE","LU0820562030.AUD","LU2047632596.USD","IE00BZ9MQY76.HKD","IE00BGHQDM52.EUR","BK4507","LU2237443622.USD","LU0784384876.USD","LU0689626769.HKD","LU0477156797.USD","IE0009356076.USD","LU2237443895.HKD","LU1868836757.USD","IE00B19Z9P08.USD","SG9999018865.SGD","LU1989763690.USD","LU2265009873.SGD","BK4512","LU1232071149.USD","LU0784385840.USD","LU2322448791.USD","BK4598","LU0234572021.USD","LU1226287875.USD","LU2505996681.GBP","LU2023250330.USD","LU2468319806.SGD","LU0096362180.USD","LU1720051108.HKD","BK4561","LU0823417653.USD","SGXZ51526630.SGD","LU0788109477.HKD","LU0314109678.HKD","LU1291159041.SGD","BK4585","SG9999014567.USD","LU0345768153.USD","SG9999015341.SGD","LU2931357623.SGD","LU0067412154.USD","SG9999000418.SGD","AVGG","IE00BSNM7G36.USD","LU0215105999.USD","LU0477156953.USD","IE00BQXX3D17.EUR","NULC","SG9999004303.SGD","IE00B894F039.SGD","LU2347655073.USD","LU1035773651.USD","SOXQ","JGRO","LU1496350171.SGD","BK4099","IE00BJLML261.HKD","LU2237957811.SGD","LU2462591277.SGD","LU0432979614.USD","SGXZ81514606.USD","LU1992135399.USD","BK4596","LU0109394709.USD","LU0724617625.USD","LU2430703095.HKD","SG9999014559.SGD","LU1989764748.USD","LU0203347892.USD","IE00BQXX3C00.GBP","UGE","LU0187121727.USD","LU1152091168.USD","IE00BMPRXQ63.HKD","LU2279689827.SGD","LU1642822529.SGD","LU2552382058.USD","LU1839511570.USD","LU2764262908.HKD","SG9999014575.USD","LU2065169927.USD","LU1201861249.SGD","IE0001KFT4U8.USD","BK4612","LU0149725797.USD","LU0130102774.USD","LU0011850046.USD","HK0000306701.USD","IE00BKPKM429.USD","LU1069347547.HKD","LU0456855351.SGD","LU0130103400.USD","AAPY","LU2247934214.USD","LU1226288170.HKD","BK4559","LU1989771016.USD","LU1670628061.USD","LU2168564495.EUR","BK4555","LU2506951958.HKD","BK4581","TTEQ","LU0310800379.SGD","LU2360032135.SGD","BK4527","LU1670756490.USD","GSK","LU0251132253.USD","IE000YTNTUN2.SGD","LU0444973449.USD","LU2430703251.USD","LU2097344431.USD","LU0158827948.USD","LU2211814178.USD","LU0256863902.USD","AVGO","LU0345769128.USD","LU2506952097.USD","LU2471134796.USD","LU1732800096.USD","LU1084165304.USD","LU1035775433.USD","LU0302445910.USD","LU0964807845.USD","LU1066053197.SGD","LU1935043536.SGD","LU2756315318.SGD","LU0274383776.USD","LU2083900584.USD","IXN","LU0106261372.USD","LU1582986433.USD","IE00BN8TJ469.HKD","LU1280957306.USD","LU1914381329.SGD","LU2092937148.SGD","IE0003U64NQ7.SGD","LU1815336760.USD","LU2106854487.HKD","IE00B42XCP33.USD","LU0203201768.USD","LU1923622614.USD","LU2111349929.HKD","LU2430703178.SGD","LU1145028129.USD","LU0289739699.SGD","IE00BFSS8Q28.SGD","LU1960683339.HKD","SPTE","LU0320765489.SGD","LU2471134952.CNY","LU1803068979.SGD","SG9999015952.SGD","SHOC","LU2023250504.SGD","SOXX","LU1316542783.SGD","IE00BVYPNQ40.USD","IE00B5MMRT66.SGD","LU2552382132.HKD","LU2100268510.USD","ROM","LU2108987350.USD","LU0289960550.SGD","LU0070217475.USD","IE000BZT7R73.USD","LU2750360997.AUD","LU1226287792.SGD","LU0708994859.HKD","LU2462157665.USD","LU2237957902.USD","LU2272731865.HKD","LU0124676726.USD","LU0965508806.USD","LU2750360641.GBP","IE00BMCWC346.EUR","LU0942090050.USD","BK4504","LU2420271590.USD","AVGW","LU2213496289.HKD","LU0234570918.USD","LU2092937221.SGD","BK4533","IE00B19Z8W00.USD","LU0965509101.SGD","BK4571","IE000MB6IJN5.SGD","LU1066051225.USD","LU2896262040.SGD","LU0289739343.SGD","LU0476273544.USD","LU2275660780.HKD","LU0315179316.USD","LU1261432733.SGD","IE00B3T34201.USD","BK1191","LU0094547139.USD","IE00B4JS1V06.HKD","LU0640476718.USD","LU2089284900.SGD","LU0889565833.HKD","LU2054465674.USD","SG9999001440.SGD","IE00B1XK9C88.USD","LU1989772923.USD","LU0175139822.USD","USXF","BK4554","LU1691799644.USD","XLK","BK4553","LU0029864427.USD","BK4515","LU0069063385.USD","IE00BBT3K403.USD","LU0784383803.USD","AVGU","SG9999015986.USD","BK4141","LU0868494708.USD","LU0211328371.USD","LU2168564065.EUR","IE000W1ABFV2.USD","LU1064131342.USD","LU1244550494.USD","LU2746668974.SGD","LU2168563687.JPY","LU0823421416.USD","IE0004091025.USD","LU1066051498.USD","LU1153585028.USD","LU1206712785.SGD","LU1974910355.USD","LU2125154935.USD","LU0326950275.SGD","LU2552382215.SGD","01093","LU1813983027.USD","BK4096","LU2954938101.SGD","LU0861579265.USD","LU1951186391.HKD","LU0170899867.USD","LU0265550946.USD","LU1868836914.USD","LU0889565916.HKD","BK4532","LU2505996509.AUD","LU0985320562.USD","IE000WAW04H5.SGD","BK1521","SG9999004220.SGD","LU1993786604.SGD","GSK.UK","LU2125909593.SGD","LU2462591350.SGD","LU1951200564.SGD","BK4579","LU0289961442.SGD","LU0417517546.SGD","LU1328277881.USD","IE00B543WZ88.USD","LU1988902786.USD","SG9999015978.USD","AAPB","AAPU","LU0157215616.USD","LU1400636574.HKD","RTH","IE00B031HY20.USD","LU2360106780.USD","LU2360108059.USD","LU2361044949.HKD","LU2461242641.AUD","LU0648000940.SGD","LU1242518857.USD","LU2637965513.SGD","LU0276348264.USD","LU0820561818.USD","LU1267930490.SGD","LU0072461881.USD","LU0345768740.USD","LU2242649171.HKD","LU0642271901.SGD","BK1515","LU1046421795.USD","LU1037948541.HKD","LU1670710588.SGD","LU1226288253.USD","LU0072462426.USD","KR","LU1069344957.HKD","LU2471134523.USD","LU0314106906.USD","LU0689472784.USD","LU0472753341.HKD","HK0000165453.HKD","SG9999002224.SGD","LU2087621335.USD","LU2237443978.SGD","IE00BZ1G4Q59.USD","LU1366333091.USD","SG9999014542.SGD","IE00B775H168.HKD","LU0979878070.USD","LU0312595415.SGD","LU1066051811.HKD","LU2087625088.SGD","LU0882574139.USD","LU2272731782.SGD","IE00BGHQF631.EUR","LU2077746001.SGD","LU0061474705.USD","LU2210150020.SGD","BK4568","LU2347655156.SGD","LU0211327993.USD","IE00BDCRKT87.USD","LU2028103732.USD","LU0511384066.AUD","HK0000306685.HKD","USD","LU0048584097.USD","IE00B775SV38.USD","LU1430594728.SGD","LU0308772762.SGD","LU2210149790.SGD","LU1506573853.SGD","LU0077335932.USD","BAI","BK4155","IE00B7KXQ091.USD","LU2237443382.USD","SGXZ99366536.SGD","AAPW","LU1152091754.HKD","IE00BVYPNP33.GBP","LU1162221912.USD","LU2458330243.SGD","HK0000532082.HKD","LU2543165471.USD","BK4543","LU0208291251.USD","LU1267930573.SGD","LU2023251221.USD","BK4588","LU1037948897.HKD","WMTI","LU2764263203.CNY","LU1935042991.SGD","LU0057025933.USD","LU0786609619.USD","IE00BK4W5L77.USD","IE00B1BXHZ80.USD","LU1496350502.SGD","METV","LU1674673428.USD","LU1861214812.USD","GB00BDT5M118.USD","LU0823421333.USD","LU1803068623.USD","LU2746668461.USD","LU1226287529.USD","LU1992135472.HKD","LU2125909247.SGD","LU1934455194.USD","LU1989772840.SGD","LU1366192091.USD","LU2471134879.HKD","LU0265550359.USD","GM","LU0949170772.SGD","MACW.SI","LU0006306889.USD","LU1008478684.HKD","IE00BLSP4452.SGD","LU0943347566.SGD","BK4113","SG9999014906.USD","LU2506951875.HKD","AVS","LU1400636491.USD","LU1934455863.HKD","LU0320765059.SGD","IE00BK4W5M84.HKD","LU0823434740.USD","LU0784385170.HKD","LU0823417737.USD","LU2237443549.SGD","LU0345769631.USD","BK4575","LU1551013342.USD","LU2236285917.USD","LU0648001328.SGD","HK0000320223.HKD","LU2381873111.SGD","LU1670627923.USD","LU0256863811.USD","LU0957791311.USD","LU0174119429.USD","LU2417539215.USD","BK4212","SG9999002232.USD","ABFL","LU1116320737.USD","LU0726765562.USD","LU1868837300.USD","IE00B19Z8X17.USD","LU1582986359.USD","BK4551","IE00B4YYXB79.USD","IE000M9KFDE8.USD","IE00BZ08YT58.USD","LU2191332357.HKD","LU0354030438.USD","IE00BDRTCR15.USD","LU0267386448.USD","LU1951198990.SGD","BK4501","LU0006061336.USD","IE00B3SWFQ91.USD","SG9999011175.SGD","IE00BN29S564.USD","LU2168564149.EUR","LU1712237335.SGD","LU0444971666.USD","LU0323591593.USD","LU1815333072.USD","LU2097829019.USD","BK4007","LU0820561909.HKD","IE00BDGV0183.EUR","LU0965509283.SGD","LU0096364046.USD","LU0266013472.USD","SGXZ23171101.USD","LU0210536198.USD","LU1670711040.USD","LU0162691827.USD","LU1935043023.USD","LU0348723411.USD","LU2168564222.USD","IE00BJJMRX11.SGD","IE0004445015.USD","LU1935042488.USD","LU2357305700.SGD","IE00BQXX3F31.USD","LU1201861165.SGD","LU2023250843.SGD","LU0320765992.SGD","LU0143551892.USD","VGT","LU2473716301.USD","LU1868837136.USD","LU2592432038.USD","LU1571399168.USD","LU0661504455.SGD","LU0980610538.SGD","LU2250418816.HKD","LU0880133367.SGD","SG9999014898.SGD","LU0056508442.USD","LU0795875086.SGD","LU0080751232.USD","LU1989763427.SGD","LU2089984988.USD","IE00BJTD4V19.USD","LU0203345920.USD","LU1935042215.USD","FAI","LU0672654240.SGD","IE00BJTD4N35.SGD","IE00BWXC8680.SGD","LU2211815571.USD","LU0070302665.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649396798","title":"GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649396798","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649396798?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:15","pubTimestamp":1783505733,"startTime":"0","endTime":"0","summary":"GSK  agreed to expand its exclusive strategic collaboration with Sino Biopharmaceutical's Chia Tai Tianqing Pharmaceutical Group subsidiary to include rights to commercialize two GSK respiratory therapies in mainland China, Sino said in a Wednesday filing.Under the deal, Chia Tai Tianqing Pharmaceutical will secure the commercialization rights to GSK's Trelegy Ellipta and Anoro Ellipta in mainland China, according to the filing. Financial details were not disclosed.The Sino unit will work with GSK to ensure smooth product rollout in China, covering supply, commercialization and regulatory compliance, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","GSK.UK","GSK","BK4588","LU1829250122.USD","BK4532","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649961643","title":"Barclays Remains a Sell on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649961643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649961643?lang=en_us&edition=fundamental","pubTime":"2026-07-08 16:46","pubTimestamp":1783500369,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £19.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4532","BK4588","LU1829250122.USD","GSK","CFA","GSK.UK","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649637389","title":"Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2649637389","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649637389?lang=en_us&edition=fundamental","pubTime":"2026-07-08 15:00","pubTimestamp":1783494000,"startTime":"0","endTime":"0","summary":"Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK PartnershipSino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payment","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","AMLP","LU1829250122.USD","UMI","TPZ","ENFR","BK4590","MLPA","BK4144","GSK","EMLP","MDST","BK4585","AMZA","USAI","BK4561","ET","EIPI","BK4532","EIPX","BK4581","BK4588","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649616957","title":"Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2649616957","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649616957?lang=en_us&edition=fundamental","pubTime":"2026-07-08 12:07","pubTimestamp":1783483636,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) just unveiled an announcement. Sino Biopharmaceutical is a leading Chinese pharmaceutical group with a strong...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-deepens-gsk-respiratory-deal-to-cement-china-lead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-deepens-gsk-respiratory-deal-to-cement-china-lead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBB","GSK.UK","BK4007","GSKH","BK4532","LU1829250122.USD","BK4585","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649931584","title":"GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2649931584","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649931584?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:30","pubTimestamp":1783441817,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 3 study called StrateGIST Frontlin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-strategist-frontline-trial-puts-new-cancer-drug-velzatinib-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-strategist-frontline-trial-puts-new-cancer-drug-velzatinib-in-the-spotlight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSKH","BK4585","GSK","BK4588","GSK.UK","LU1829250122.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871150","title":"HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173871150?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:12","pubTimestamp":1783422743,"startTime":"0","endTime":"0","summary":"HANXBIO-B has announced a strategic partnership aimed at harnessing the power of artificial intelligence to revolutionize the drug development process.The company has entered into a formal agreement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK1173","AIPO","BK1161","BK1535","CHAT","IBB","PBE","03378","VTHR","GSKH","AGIX","WRND","BK4588","BK4585","BBP","ARTY","GDOC","QTOC","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649163671","title":"Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2649163671","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649163671?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:34","pubTimestamp":1783370099,"startTime":"0","endTime":"0","summary":"Global pharma is back in the political spotlight, as US pressure on drug prices abroad collides with European cost controls and fresh trade tensions. For investors, this mix of policy risk and pricing shifts could change how large pharmaceutical stocks are viewed, especially those with significant US and European exposure. This article looks at three large-cap global pharmaceutical companies from our screener that appear especially exposed to the latest headlines, and explains why some...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/275442-main-header/1585186835888","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/275442-main-header/1585186835888"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-gsk/gsk-shares/news/drug-pricing-pressure-puts-gsk-and-global-pharma-stocks-in-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-gsk/gsk-shares/news/drug-pricing-pressure-puts-gsk-and-global-pharma-stocks-in-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BJT1NW94.SGD","VHT","RXL","GSK","LU1894683348.USD","IXJ","LU1032466523.USD","LU1732799900.SGD","LU1935042991.SGD","LU2750360641.GBP","JDOC","IE000SO60NU8.SGD","XLV","LU1023059063.AUD","LU1196500208.SGD","MEDX","IYH","LU2347655156.SGD","PJP","LU2430703251.USD","BMED","VTRS","IE00B7SZLL34.SGD","GSKH","LU2468319806.SGD","FHLC","IE00B3PB1722.GBP","LU2505996681.GBP","JNJ","LU1839511570.USD","LU2471134523.USD","LU1983299246.USD","IE00BSNM7G36.USD","LU1244550577.SGD","BK4559","LU2023250330.USD","IHE","FTXH","IE000MB6IJN5.SGD","LU1496350502.SGD","GSK.UK","LU0058720904.USD","LU1228905540.USD","LU0912757837.SGD","GDOC","LU2471134796.USD","LU1074936037.SGD","LU0994945656.USD","LU0466842654.USD","LU1280957306.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137018709","title":"Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137018709","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137018709?lang=en_us&edition=fundamental","pubTime":"2026-07-02 23:47","pubTimestamp":1783007267,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector is once again experiencing a rotation of capital inflows.GlaxoSmithKline PLC (GSK.US) shares are up nearly 5%. Novo Nordisk A/S (NVO.US) and Sanofi (SNY.US) have gained more...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK4532","BK1574","GSKH","BK1161","159938","GSK","BK1515","GSK.UK","BK4585","BK4588","BK4007","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648620563","title":"GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2648620563","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648620563?lang=en_us&edition=fundamental","pubTime":"2026-07-01 00:30","pubTimestamp":1782837058,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Tests Dual mRNA Vaccine for Flu and COVID-19 in Older Adults. The s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-mrna-combo-shot-targets-flu-and-covid-19-in-one-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-mrna-combo-shot-targets-flu-and-covid-19-in-one-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU1829250122.USD","BK4551","BK4548","BK4139","GSK","GSK.UK","GSKH","BK4532","BK4585","BK4535","BNTX","BK4568","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370385","title":"GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647370385?lang=en_us&edition=fundamental","pubTime":"2026-06-29 22:03","pubTimestamp":1782741803,"startTime":"0","endTime":"0","summary":"An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has completed a share buyback programme of up to £2 billion, executed thro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-completes-2-billion-share-buyback-lifts-treasury-holdings-to-6-7-of-voting-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-completes-2-billion-share-buyback-lifts-treasury-holdings-to-6-7-of-voting-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSKH","GSK","BK4532","BK4585","GSK.UK","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647332685","title":"GlaxoSmithKline (GSK) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2647332685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647332685?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:35","pubTimestamp":1782714923,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £19.00. Gordon CFA covers the Healthc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","BK4588","BK4585","GSK.UK","BK4007","GSK","LU1829250122.USD","CFA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646361946","title":"GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2646361946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646361946?lang=en_us&edition=fundamental","pubTime":"2026-06-27 00:30","pubTimestamp":1782491419,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The Extended Salford Lung Study (Ex-SLS) Data Access Project from GSK t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-extended-salford-lung-study-what-a-terminated-data-project-still-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-extended-salford-lung-study-what-a-terminated-data-project-still-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4532","BK4588","GSK.UK","GSK","BK4211","ISBC","GSKH","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365150","title":"Dodge & Cox lifts GSK stake above 5% as institutional backing grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365150","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646365150?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:28","pubTimestamp":1782484090,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GSK) ). On 23 June 2026, U.S. investment manager Dodge & Cox increased its stake in GSK plc, cros...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dodge-cox-lifts-gsk-stake-above-5-as-institutional-backing-grows?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dodge-cox-lifts-gsk-stake-above-5-as-institutional-backing-grows?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","BK4532","GSK.UK","GSK","LU1829250122.USD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646027078","title":"GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646027078","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646027078?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:31","pubTimestamp":1782405113,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running the BALANCE Phase 2b study to test camlipixa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-balance-trial-new-ibs-drug-candidate-moves-through-midstage-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-balance-trial-new-ibs-drug-candidate-moves-through-midstage-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSKH","GSK","BK4532","BK4585","GSK.UK","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646020628","title":"GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2646020628","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646020628?lang=en_us&edition=fundamental","pubTime":"2026-06-26 00:31","pubTimestamp":1782405105,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running the Phase 3b/4 MODIFY study to test early us...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-modify-asthma-trial-early-biologic-bet-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-modify-asthma-trial-early-biologic-bet-with-long-term-upside-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4588","GSK","GSKH","BK4532","BK4007","BK4585","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646824383","title":"Gsk's HIV Franchise Seems Underappreciated","url":"https://stock-news.laohu8.com/highlight/detail?id=2646824383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646824383?lang=en_us&edition=fundamental","pubTime":"2026-06-25 14:06","pubTimestamp":1782367560,"startTime":"0","endTime":"0","summary":"0605 GMT - HIV treatments look set to undergo a major transformation in the coming decades, and GSK's potential in this market seems underappreciated, Bernstein analysts say in a research note. With Britain's GSK and American rival Gilead Sciences commanding a combined 90% share of the U.S. HIV market, this is essentially a duopoly, according to Bernstein. Existing HIV drugs are already very effective, but upcoming innovations that will help move patients to long-acting injectable drugs from daily tablets is expected to drive future market growth, the analysts say. The U.S. HIV market is expected to grow to $37 billion in 2040, up from $26 billion last year, with GSK's share projected to rise to 44% from 26% over the same time horizon, they estimate.  Dow Jones NewswiresJune 25, 2026 02:06 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","GSK","IE00B7SZLL34.SGD","LU1037948541.HKD","IE00B19Z3581.USD","LU0122379950.USD","SG9999015952.SGD","LU1674673428.USD","LU1061106388.HKD","IE00BKVL7J92.USD","BK4578","LU1934455194.USD","LU1674673691.USD","BK4532","LU0320765992.SGD","BK4566","LU1430594728.SGD","LU0058720904.USD","GSKH","IE00BZ1G4Q59.USD","BK4585","BK4007","BK4588","LU1839511570.USD","SG9999015945.SGD","LU0289739699.SGD","BK4568","SG9999015986.USD","LU1037948897.HKD","GILD","IE00B3T34201.USD","LU0965509283.SGD","GSK.UK","LU0114720955.EUR","BK4550","BK4139","LU1023059063.AUD","BK4583","LU0234570918.USD","LU1934455863.HKD","SG9999015978.USD","LU0823416689.USD","LU2324357040.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU2089984988.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU1829250122.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646812246","title":"GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2646812246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646812246?lang=en_us&edition=fundamental","pubTime":"2026-06-25 00:31","pubTimestamp":1782318667,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Tests New Dosing for Key Myeloma Drug in Phase 2 Trial. This new st...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-revamps-belantamab-dosing-in-new-multiple-myeloma-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-revamps-belantamab-dosing-in-new-multiple-myeloma-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GSKH","BK4588","GSK.UK","LU1829250122.USD","BK4007","BK4211","BK4532","GSK","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646781288","title":"GSK Unit Launches Tender Offer for Nuvalent Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2646781288","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646781288?lang=en_us&edition=fundamental","pubTime":"2026-06-25 00:02","pubTimestamp":1782316952,"startTime":"0","endTime":"0","summary":"GSK  said Wednesday its Harmony Row Acquisition unit commenced a tender offer to purchase all outstanding Class A and Class B shares of Nuvalent  for $124 per share in cash.Following the consummation of the offer, the unit will merge into Nuvalent, which will continue as a direct wholly-owned subsidiary of GlaxoSmithKline LLC.Nuvalent's board of directors recommended that stockholders accept the offer and tender their shares, GSK said.The tender offer and withdrawal rights will expire on July 14, the company added.Price: 51.20, Change: -0.87, Percent Change: -1.67","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","NUVL","GSK","BK4585","BK4139","BK4007","BK4532","BK4588","GSKH","BK4539","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645811812","title":"GSK Discloses Executive Notional ADS Acquisition by U.S. President","url":"https://stock-news.laohu8.com/highlight/detail?id=2645811812","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645811812?lang=en_us&edition=fundamental","pubTime":"2026-06-24 22:32","pubTimestamp":1782311549,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GSK has disclosed a transaction involving Maya Martinez-Davis, President of its U.S. business, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-executive-notional-ads-acquisition-by-u-s-president?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-executive-notional-ads-acquisition-by-u-s-president?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","BK4588","BK4585","BK4532","LU1829250122.USD","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}